Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Analgesics, antiemetics, steroids, and radiation therapy are effective in helping
to control symptoms caused by cancer. It is not yet known whether these treatments are more
effective when given with or without docetaxel in treating patients with relapsed esophageal
cancer or stomach cancer.
PURPOSE: This randomized phase II trial is studying symptom control given together with
docetaxel to see how well it works compared with symptom control given without docetaxel in
treating patients with relapsed esophageal cancer or stomach cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust